Cargando…
Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
Immunotherapy has shown great promise in the field of oncology, and recent clinical trials have illustrated that immune checkpoint blockade (ICB) is safe and effective at treating a range of tumor types. Cervical cancer (CC) is the fourth most common malignancy in women. However, first-line treatmen...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832370/ https://www.ncbi.nlm.nih.gov/pubmed/36644634 http://dx.doi.org/10.3389/fonc.2022.1045481 |